An essential tool in the compliance with DEA regulation.
A must have for Retail, Automotive and Pharmaceutical suppliers who require EDI compliant transactions and labels.
Title II of the Drug Quality and Security Act (DQSA), passed in November 2013, is unusually detailed in its specified actions and deadlines compared to much federal legislation; usually, a law is passed with general goals and dates, and then the appropriate regulatory agencies develop specific regulations and timetables. But the entire dynamic of DQSA—the end product of a decade or more of Congressional bills, hearings, prior law and litigation—was...Keep Reading
According to statements from the US Attorney, Northern District of California, and FedEx, the US Dept. of Justice is charging FedEx with “conspiracy to traffic in controlled substances,” mostly arising from the practice, common several years ago but less so now, of handling shipments from online “pharmacies” (many of which are not actually pharmacies) that sell controlled substances and other drugs to US consumers directly. FedEx is entangled in this dispute because it handled the shipments, which date back to 2004... Keep Reading